BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,067 filers reported holding BAXTER INTL INC in Q2 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $396,383 | -17.8% | 10,503 | -0.7% | 0.10% | -17.7% |
| Q2 2023 | $481,934 | +10.2% | 10,578 | -1.9% | 0.12% | +3.3% |
| Q1 2023 | $437,156 | -20.7% | 10,778 | -0.4% | 0.12% | -25.5% |
| Q4 2022 | $551,393 | -5.7% | 10,818 | -0.4% | 0.16% | -18.7% |
| Q3 2022 | $585,000 | +185.4% | 10,861 | +342.6% | 0.20% | +266.7% |
| Q4 2019 | $205,000 | -4.7% | 2,454 | 0.0% | 0.05% | -52.2% |
| Q3 2019 | $215,000 | +7.0% | 2,454 | 0.0% | 0.11% | +56.9% |
| Q2 2019 | $201,000 | -7.8% | 2,454 | -8.4% | 0.07% | -12.2% |
| Q1 2019 | $218,000 | +23.9% | 2,679 | 0.0% | 0.08% | -24.1% |
| Q4 2018 | $176,000 | -5.4% | 2,679 | +11.0% | 0.11% | +9.1% |
| Q3 2018 | $186,000 | -8.4% | 2,414 | -12.1% | 0.10% | -12.4% |
| Q2 2018 | $203,000 | +22.3% | 2,746 | +7.9% | 0.11% | +18.9% |
| Q1 2018 | $166,000 | +0.6% | 2,546 | 0.0% | 0.10% | +4.4% |
| Q4 2017 | $165,000 | +3.1% | 2,546 | 0.0% | 0.09% | -1.1% |
| Q3 2017 | $160,000 | +3.2% | 2,546 | 0.0% | 0.09% | -3.2% |
| Q2 2017 | $155,000 | +15.7% | 2,546 | 0.0% | 0.10% | +8.0% |
| Q1 2017 | $134,000 | -8.2% | 2,546 | -16.6% | 0.09% | -17.0% |
| Q4 2016 | $146,000 | 0.0% | 3,053 | 0.0% | 0.11% | 0.0% |
| Q3 2016 | $146,000 | -32.4% | 3,053 | -36.1% | 0.11% | -29.8% |
| Q2 2016 | $216,000 | – | 4,778 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
| GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
| Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
| Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
| Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
| Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
| TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
| CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
| Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
| Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |